Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo

Pediatric Research

Volumn 74, Issue 6, 2013, Pages 646-651

  Taponen, Saija ^a   Huusko, Johanna M ^a   Petäjä Repo, Ulla E ^a   Paananen, Reija ^a,b   Guttentag, Susan H ^c   Hallman, Mikko ^a,d   Haataja, Ritva ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SURFACTANT PROTEIN B;

ALLELE; AMNION FLUID ANALYSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DELIVERY; DNA POLYMORPHISM; FEMALE; FETUS; FETUS LUNG; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GLYCOSYLATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG DISEASE; LUNG PARENCHYMA; POSTTRANSCRIPTIONAL GENE SILENCING; PREGNANCY; PRIORITY JOURNAL; PROTEIN SECRETION; SFTPB GENE;

ALLELES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSYLATION; HUMANS; ISOLEUCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; THREONINE;

EID: 84890642061     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.151     Document Type: Article

References (39)

1. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-76.
2. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-67.
3. Chroneos ZC, Sever-Chroneos Z, Shepherd VL. Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 2010;25:13-26.
4. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:1860-3.
5. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92:7794-8.
6. Guttentag S. Posttranslational regulation of surfactant protein B expression. Semin Perinatol 2008;32:367-70.
7. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555-78.
8. van Iwaarden JF, Claassen E, Jeurissen SH, Haagsman HP, Kraal G. Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways. Am J Respir Cell Mol Biol 2001;24:452-8.
9. Epaud R, Ikegami M, Whitsett JA, Jobe AH, Weaver TE, Akinbi HT. Surfactant protein B inhibits endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 2003;28:373-8.
10. Beers MF, Shuman H, Liley HG, et al. Surfactant protein B in human fetal lung: developmental and glucocorticoid regulation. Pediatr Res 1995;38:668-75.
11. Guttentag SH, Beers MF, Bieler BM, Ballard PL. Surfactant protein B processing in human fetal lung. Am J Physiol 1998;275(3 Pt 1):L559-66.
12. Guttentag S, Robinson L, Zhang P, Brasch F, Bühling F, Beers M. Cysteine protease activity is required for surfactant protein B processing and lamellar body genesis. Am J Respir Cell Mol Biol 2003;28:69-79.
13. Korimilli A, Gonzales LW, Guttentag SH. Intracellular localization of processing events in human surfactant protein B biosynthesis. J Biol Chem 2000;275:8672-9.
14. Breslin JS, Weaver TE. Binding, uptake, and localization of surfactant protein B in isolated rat alveolar type II cells. Am J Physiol 1992;262(6 Pt 1):L699-707.
15. Marttila R, Haataja R, Guttentag S, Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 2003;168:1216-22.
16. Wang G, Christensen ND, Wigdahl B, Guttentag SH, Floros J. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. Biochem J 2003;369(Pt 1):179-84.
17. Haataja R, Rämet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000;9:2751-60.
18. Lin Z, Pearson C, Chinchilli V, et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000;58:181-91.
19. Selman M, Lin HM, Montaño M, et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 2003;113:542-50.
20. Quasney MW, Waterer GW, Dahmer MK, et al. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 2004;32:1115-9.
21. Floros J, Fan R, Diangelo S, Guo X, Wert J, Luo J. Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr Int 2001;43:567-76.
22. Sherry ST, Ward M, Sirotkin K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 1999;9:677-9.
23. Steagall WK, Lin JP, Moss J. The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B. Am J Physiol Lung Cell Mol Physiol 2007;292:L448-53.
24. Thomas KH, Meyn P, Suttorp N. Single nucleotide polymorphism in 5'-flanking region reduces transcription of surfactant protein B gene in H441 cells. Am J Physiol Lung Cell Mol Physiol 2006;291:L386-90.
25. Floros J, Veletza SV, Kotikalapudi P, et al. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 1995;305 (Pt 2):583-90.
26. Makri V, Hospes B, Stoll-Becker S, Borkhardt A, Gortner L. Polymorphisms of surfactant protein B encoding gene: modifiers of the course of neonatal respiratory distress syndrome? Eur J Pediatr 2002;161:604-8.
27. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004;13:1095-104.
28. Melton KR, Nesslein LL, Ikegami M, et al. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003;285:L543-9.
29. Hallman M, Merritt TA, Akino T, Bry K. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991;144:1376-84.
30. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991;30:597-605.
31. Dilger I, Schwedler G, Dudenhausen JW. Determination of the pulmonary surfactant-associated protein SP-B in amniotic fluid with a competition ELISA. Gynecol Obstet Invest 1994;38:24-7.
32. Aebi M, Bernasconi R, Clerc S, Molinari M. N-glycan structures: recognition and processing in the ER. Trends Biochem Sci 2010;35:74-82.
33. Isosomppi J, Västinsalo H, Geller SF, Heon E, Flannery JG, Sankila EM. Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane. Mol Vis 2009;15:1806-18.
34. Antenos M, Stemler M, Boime I, Woodruff TK. N-linked oligosaccharides direct the differential assembly and secretion of inhibin alpha- and beta Asubunit dimers. Mol Endocrinol 2007;21:1670-84.
35. Bas T, Gao GY, Lvov A, Chandrasekhar KD, Gilmore R, Kobertz WR. Posttranslational N-glycosylation of type I transmembrane KCNE1 peptides: implications for membrane protein biogenesis and disease. J Biol Chem 2011;286:28150-9.
36. Vogt G, Vogt B, Chuzhanova N, Julenius K, Cooper DN, Casanova JL. Gain-of-glycosylation mutations. Curr Opin Genet Dev 2007;17:245-51.
37. Markkanen PM, Petäjä-Repo UE. N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface. J Biol Chem 2008;283:29086-98.
38. Gerk PM. Quantitative immunofluorescent blotting of the multidrug resistance-associated protein 2 (MRP2). J Pharmacol Toxicol Methods 2011;63:279-82.
39. Schutz-Geschwender A, Zhang Y, Holt T, McDermitt D, Olive D. Quantitative, two-color western blot detection with infrared fluorescence. LI-COR Biosciences, 2004. (http://www.licor.com/bio/PDF/IRquant.pdf.)